|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | HCV-Related Nervous System Disorders显示文摘 | Salvatore Monaco Sergio Ferrari Alberto Gajofatto Gianluigi Zanusso Sara Mariotto Domenico Sansonno | 2012 | Clinical and Developmental Immunology2012，，： | 4 |
| 2 | The safety of energy-based devices in open thyroidectomy: a prospective, randomised study comparing the LigaSure? (LF1212) and the Harmonic? FOCUS显示文摘 | Gianlorenzo Dionigi Luigi Boni Stefano Rausei Francesco Frattini Cesare Ferrari Alberto Mangano Andrea Leotta Marco Franchin | 2012 | Langenbeck’s Archives of Surgery2012，，5： | 2 |
| 3 | Localization of a Novel Locus for Autosomal Recessive Early-Onset Parkinsonism, PARK6, on Human Chromosome 1p35-p36显示文摘 | Enza Maria Valente Anna Rita Bentivoglio Peter H. Dixon Alessandro Ferraris Tamara Ialongo Marina Frontali Alberto Albanese Nicholas W. Wood | 2001 | The American Journal of Human Genetics2001，，4： | 1 |
| 4 | Open-Label, Randomized, Placebo-Controlled Evaluation of Intracoronary Adenosine or Nitroprusside After Thrombus Aspiration During Primary Percutaneous Coronary Intervention for the Prevention of Microvascular Obstruction in Acute Myocardial Infarction显示文摘 | Giampaolo Niccoli Stefano Rigattieri Maria Rosaria De Vita Marco Valgimigli Pierfrancesco Corvo Franco Fabbiocchi Enrico Romagnoli Alberto Ranieri De Caterina Giuseppe La Torre Paolo Lo Schiavo Fabio Tarantino Roberto Ferrari Fabrizio Tomai Paolo Olivares | 2013 | JACC: Cardiovascular Interventions2013，，： | 1 |
| 5 | When to Perform Bone Scan in Patients with Newly Diagnosed Prostate Cancer: External Validation of the Currently Available Guidelines and Proposal of a Novel Risk Stratification Tool 显示文摘 | Alberto Briganti Niccolò Passoni Matteo Ferrari Umberto Capitanio Nazareno Suardi Andrea Gallina Luigi Filippo Da Pozzo Maria Picchio Valerio Di Girolamo Andrea Salonia Liugi Gianolli Cristina Messa Patrizio Rigatti Francesco Montorsi | 2009 | European Urology2009，，4： | 1 |
| 6 | Subkilohertz fluctuations and mode hopping in high-power grating-stabilized 980-nm pumps 显示文摘 | Alberto Ferrari Giorgio Ghislotti | 2002 | Journal of Lightwave Technology2002，20，3： | 1 |
| 7 | Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders:Advances in 2015显示文摘Since its identification in 1989, hepatitis C virus(HCV) has emerged as a worldwide health problem with roughly 185 million chronic infections, representing individuals at high risk of developing cirrhosis and liver cancer. In addition to being a frequent cause of morbidity and mortality due to liver disease, HCV has emerged as an important trigger of lymphoproliferative disorders, owing to its lymphotropism, and of a wide spectrum of extrahepatic manifestations(HCV-EHMs) affecting different organ systems. The most frequently observed HCV-EHMs include mixed cryoglobulinemia and cryoglobulinemic vasculitis, B-cell non-Hodgkin's lymphoma, nephropathies, thyreopathies, type 2 diabetes mellitus, cardiovascular diseases, and several neurological conditions. In addition, neuropsychiatric disorders and neurocognitive dysfunction are reported in nearly 50% of patients with chronic HCV infection, which are independent of the severity of liver disease or HCV replication rates. Fatigue, sleep disturbance, depression and reduced quality of life are commonly associated with neurocognitive alterations in patients with non-cirrhotic chronic HCV infection, regardless of the stage of liver fibrosis and the infecting genotype. These manifestations, which are the topic of this review, typically occur in the absence of structural brain damage or signal abnormalities on conventional brain magnetic resonance imaging(MRI), although metabolic and microstructural changes can be detected by in vivo proton magnetic resonance spectroscopy, perfusion-weighted and diffusion tensorMRI, and neurophysiological tests of cognitive processing. Several lines of evidence, including comparative and longitudinal neuropsychological assessments in patients achieving spontaneous or treatment-induced viral clearance, support a major pathogenic role for HCV in neuropsychiatric and neurocognitive disorders. | Salvatore Monaco Sara Mariotto Sergio Ferrari Massimiliano Calabrese Gianluigi Zanusso Alberto Gajofatto Domenico Sansonno Franco Dammacco | 2015 | World Journal of Gastroenterology2015，21，42： | 1 |
| 8 | Comparing Attendance and Detection Rate of Colonoscopy With Sigmoidoscopy and FIT for Colorectal Cancer Screening显示文摘 | Nereo Segnan Carlo Senore Bruno Andreoni Alberto Azzoni Luigi Bisanti Alessandro Cardelli Guido Castiglione Cristiano Crosta Andrea Ederle Alberto Fantin Arnaldo Ferrari Mario Fracchia Franco Ferrero Stefano Gasperoni Serafino Recchia Mauro Risio Tiziana | 2007 | Gastroenterology2007，，7： | 1 |
| 9 | Influence of left ventricular mass, uremia and hypertension on vagal tachycardic reserve显示文摘 | Luca Mircoli Rodolfo Rivera Giuseppe Bonforte Luigi Fedele Simonetta Genovesi Maurizio Surian Alberto U Ferrari | 2003 | Journal of Hypertension2003，，8： | 1 |
| 10 | Blood Pressure and Heart Rate Variabilities in Normotensive and Hypertensive Human Beings显示文摘 | Giuseppe Mancia Alberto Ferrari Luisa Gregorini Gianfranco Parati Guido Pomidossi Giovanni Bertinieri Guido Grassi Marco di Rienzo Antonio Pedotti Alberto Zanchetti | 1983 | Circulation Research1983，，1： | 1 |
| 11 | Emergency colonoscopy显示文摘 | Francesco Paolo Rossini M.D. Arnaldo Ferrari M.D. Mauro Spandre M.D. Mariella Cavallero M.D. Carlo Gemme M.D. Carlo Loverci M.D. Alberto Bertone M.D. Marco Pinna Pintor M.D | 1989 | World Journal of Surgery1989，，2： | 1 |
| 12 | Design of ceramic tiles with high solar reflectance through the development of a functional engobe显示文摘 | Chiara Ferrari Antonio Libbra Alberto Muscio Cristina Siligardi | 2013 | Ceramics International2013，，： | 1 |
| 13 | Chromium-free catalysts for selective vapor phase hydrogenation of maleic anhydride to γ-butyrolactone显示文摘 | Gian Luca Castiglioni Maria Ferrari Alberto Guercio | 1996 | Catalysis Today1996，27，12： | 1 |
| 14 | Effectiveness of Unsedated Transnasal Endoscopy With White-light, Flexible Spectral Imaging Color Enhancement, and Lugol Staining for Esophageal Cancer Screening in High-risk Patients显示文摘 | Vitor Arantes Walton Albuquerque Jose Maria Porcaro Salles Carlos Alberto Freitas Dias Luiz Ronaldo Alberti Michel Kahaleh Teresa Cristina Abreu Ferrari Luiz Gonzaga Vaz Coelho | 2013 | Journal of Clinical Gastroenterology2013，，4： | 1 |
| 15 | HCV-Related Nervous System Disorders显示文摘 | Salvatore Monaco Sergio Ferrari Alberto Gajofatto Gianluigi Zanusso Sara Mariotto Domenico Sansonno | 2012 | Clinical and Developmental Immunology2012，，： | 1 |
| 16 | L.ong-term recovery of normal sexual function in lesticular cancer survivors显示文摘阴囊的癌症(TC ) 是在在生活的第三和第四十年之间的人的最普通的稳固的癌症。由于成功的治疗途径, TC 幸存者(TCS ) 有长寿预期,但是与众多的潜在的长期的 sequelae,包括性机能障碍。我们调查了长期的正常的预言者在 TCS 的性功能(SF ) 恢复。Sociodemographic,医药,并且 psychometric 数据在 143 白种人欧洲人 TCS 被分析,在一个单个机构经历了 orchiectomy。健康重要的 comorbidities 与 Charlson Comorbidity 索引(CCI ) 被获得。病人们完成了可勃起的功能(IIEF ) 的国际索引。统计模型测试了在预言者之间的协会(包括在外科,身体团索引, CCI,和辅助治疗的年龄:放射疗法[ RT ],化疗[ CT ], CT 由 retroperitoneal 淋巴节点解剖列在后面[ RPLND ]并且 RPLND 独自一个)并且正常 SF 的长期的恢复(定义同样IIEF可勃起的功能[ EF ] 26 ,并且性欲望[ SD ],交际满足[]高潮的功能[],并且全面满足[ OS ]在上面的 tertiles 的域分数)。在 86 个月的吝啬的后续, 35 (25.5%) TCS 有可勃起的机能障碍(编辑) ,(11.2%) 与 16 经历 EF 恢复的中部的时间是的严重编辑在 CT, RT,和 RPLND 以后的 60, 60,和 70 个月分别地。仅仅辅助的 RT 作为正常 EF 的 nonrecovery 的一个独立预言者出现了(HR:0.55, P= 0.01 ) 。加 RPLND 或 RPLND 的既不辅助 CT 也不 CT 显著地独自损害了正常勃起的恢复。辅助治疗没总体上与正常的性的损害恢复被联系,认为 IIEF-SD, -OF,-IS, 和 OS 是领域。 | Paolo Capogrosso Luca Boeri Matteo Ferrari Eugenio Ventimiglia Giovanni La Croce Umberto Capitanio Alberto Briganti Rocco Damiano Francesco Montorsi Andrea Salonia | 2016 | Asian Journal of Andrology2016，18，1： | 1 |
| 17 | Effectiveness of Unsedated Transnasal Endoscopy With White-light, Flexible Spectral Imaging Color Enhancement, and Lugol Staining for Esophageal Cancer Screening in High-risk Patients显示文摘 | Vitor Arantes Walton Albuquerque Jose Maria Porcaro Salles Carlos Alberto Freitas Dias Luiz Ronaldo Alberti Michel Kahaleh Teresa Cristina Abreu Ferrari Luiz Gonzaga Vaz Coelho | 2013 | Journal of Clinical Gastroenterology2013，，4： | 1 |
| 18 | FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study显示文摘 | Alberto Zaniboni Enrico Aitini Sandro Barni Daris Ferrari Stefano Cascinu Vincenzo Catalano Giuseppe Valmadre Domenica Ferrara Enzo Veltri Claudio Codignola Roberto Labianca | 2012 | Cancer Chemotherapy and Pharmacology2012，，6： | 1 |
| 19 | Surgical management of tegmen defects of the temporal bone and meningoencephalic herniation: our experience显示文摘1. Introduction The tegmental wall of the tympanic cavity is a thin plate of the temporal bone that separates the middle cranial fossa(MCF) from the ear. This anatomical region consists of two areas: an anterior one, comprised of the tegmen tympani(To′th et al., 2007), and a posterior one, formed by the tegmen antri and the tegmen mastoideum(Makki et al., 2011). In some patients, the tegmental region of the temporal bone can be interrupted, causing a tegmen defect(TD). A TD is sometimes associated with a meningoencephalic herniation(MEH), in which brain tissue herniates through a TD. | Giuseppe De Donato Emanuela Fuccillo Alberto Maria Saibene Elena Ferrari Giorgia Carlotta Pipolo Antonia Pisani Liliana Colletti Anastasia Urbanelli Luigi De Donato Giovanni Felisati | 2024 | Journal of Otology2024，19，1： | 0 |
| 20 | Serial physical examinations, a simple and reliable tool for managing neonates at risk for early-onset sepsis显示文摘AIM To investigate whether serial physical examinations(SPEs) are a safe tool for managing neonates at risk for early-onset sepsis(EOS). METHODS This is a retrospective cohort study of neonates(≥ 34 wks' gestation) delivered in three high-volume level Ⅲbirthing centres in Emilia-Romagna(Italy) during a 4-mo period(from September 1 to December 31, 2015). Neonates at risk for EOS were managed according to the SPEs strategy, these were carried out in turn by bedside nursing staff and physicians. A standardized form detailing general wellbeing, skin colour and vital signs was filled in and signed at standard intervals(at age 3, 6, 12, 18, 36 and 48 h) in neonates at risk for EOS. Three independent reviewers reviewed all charts of neonates and abstracted data(gestational age, mode of delivery, group B streptococcus status, risk factors for EOS, duration of intrapartum antibiotic prophylaxis, postpartum evaluations, therapies and outcome). Rates of sepsis workups, empirical antibiotics and outcome of neonates at-risk(or not) for EOS were evaluated.RESULTS There were 2092 live births and 1 culture-proven EOS(Haemophilus i)(incidence rates of 0.48/1000 live births). Most newborns with signs of illness(51 out of 101, that is 50.5%), and most of those who received postpartum antibiotics(17 out of 29, that is 58.6%) were not at risk for EOS. Compared to neonates at risk, neonates not at risk for EOS were less likely to have signs of illness(51 out of 1442 vs 40 out of 650, P = 0.009) or have a sepsis workup(25 out of 1442 vs 28 out of 650, P < 0.001). However, they were not less likely to receive empirical antibiotics(17 out of 1442 vs 12 out of 650, P = 0.3). Thirty-two neonates were exposed to intrapartum fever or chorioamnionitis: 62.5%(n = 20) had a sepsis workup and 21.9%(n = 7) were given empirical antibiotics. Among 216 neonates managed through the SPEs strategy, only 5.6%(n = 12) had subsequently a sepsis workup and only 1.9%(n = 4) were given empirical antibiotics. All neonates managed through SPEs had a normal outcome. Among 2092 neonates, only 1.6%(n = 34) received antibiotics; 1.4%(n = 29) were ill and 0.2%(n = 5) were asymptomatic(they were treated because of risk factors for EOS). CONCLUSION The SPEs strategy reduces unnecessary laboratory evaluations and antibiotics, and apparently does not worsen the outcome of neonates at-risk or neonates with mild, equivocal, transient symptoms. | Alberto Berardi Anna Maria Buffagni Cecilia Rossi Eleonora Vaccina Chiara Cattelani Lucia Gambini Federica Baccilieri Francesca Varioli Fabrizio Ferrari | 2016 | World Journal of Clinical Pediatrics2016，5，4： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员